Related Experiment Video
Updated: May 8, 2026

Method of Direct Segmental Intra-hepatic Delivery Using a Rat Liver Hilar Clamp Model
Published on: April 2, 2017
Regulation of molecular pathways in ischemia-reperfusion injury after liver transplantation
Ricardo C Gehrau1, Valeria R Mas, Catherine I Dumur
11 Transplant Division, Department of Surgery, University of Virginia, Charlottesville, VA. 2 Department of Pathology, Virginia Commonwealth University, Richmond, VA. 3 Address correspondence to Daniel G. Maluf, M.D., Liver Transplant Program, Transplant Division, Department of Surgery, University of Virginia, 1300 Jefferson Park Avenue, Barringer 5, Room 5417, Charlottesville, VA.
Background:
Ischemia-reperfusion (I/R) injury is a multifactorial phenomenon that occurs during the transplant event and frequently compromises early graft function after liver transplantation (LT). Current comprehension of molecular mechanisms and regulation processes of I/R injury lacks clarity. MicroRNA (miRNA) regulation results critical in several biological processes.
Methods:
This study evaluated gene expression and miRNA expression profiles using microarrays in 34 graft biopsies collected at preimplantation (L1) and at 90 min postreperfusion (L2) from consecutives deceased-donor LT recipients. miRNA profiles were first analyzed. Data integration analysis (gene expression/miRNA expression) aimed to identify potential target genes for each identified miRNA from the L1/L2 differential gene expression profile.
Results:
Pairwise comparison analyses identified 40 miRNAs and 3168 significantly differentially expressed genes at postreperfusion time compared with preimplantation time. Pathway analysis of miRNAs associated these profiles with antiapoptosis, inhibition of cellular proliferation, and proinflammatory processes. Target analysis identified an miRNA-associated molecular profile of 2172 genes involved in cellular growth and proliferation modulation by cell cycle regulation, cell death and survival, and proinflammatory and anti-inflammatory processes. miRNA-independent genes involved proinflammatory molecules.
Conclusion:
We identified a miRNA profile involved in posttranscriptional regulatory mechanisms in I/R injury post-LT. A better understanding of these molecular processes involved in I/R may contribute to develop new strategies to minimize graft injury.
Insights
Researchers identified microRNA (miRNA) profiles involved in regulating ischemia-reperfusion (I/R) injury after liver transplantation (LT). Understanding these molecular processes may help minimize graft injury and improve transplant outcomes.
Area of Science:
- Transplantation immunology
- Molecular biology
- Genomics
Background:
- Ischemia-reperfusion (I/R) injury is a significant complication after liver transplantation (LT), impacting early graft function.
- The molecular mechanisms underlying I/R injury are not fully understood.
- MicroRNAs (miRNAs) play crucial roles in regulating biological processes.
Purpose of the Study:
- To investigate the role of miRNA expression profiles in I/R injury following LT.
- To identify potential miRNA targets involved in I/R injury pathogenesis.
- To elucidate the molecular regulatory mechanisms of I/R injury.
Main Methods:
- Gene and miRNA expression profiling using microarrays on liver graft biopsies.
- Biopsies were collected preimplantation (L1) and 90 minutes postreperfusion (L2) from LT recipients.
- Integrated analysis of gene and miRNA expression data to identify miRNA-target gene interactions.
Main Results:
- Identified 40 differentially expressed miRNAs and 3168 differentially expressed genes between preimplantation and postreperfusion stages.
- miRNA profiles were associated with anti-apoptosis, inhibition of cellular proliferation, and proinflammatory processes.
- miRNA-target analysis revealed a profile of 2172 genes involved in cell cycle regulation, cell death, and inflammatory responses.
Conclusions:
- A distinct miRNA profile is involved in posttranscriptional regulation of I/R injury in liver grafts.
- Understanding these miRNA-mediated regulatory mechanisms is key to developing novel therapeutic strategies.
- This research contributes to minimizing graft injury and improving outcomes in liver transplantation.
